Nouveau Life Pharmaceuticals, Inc. (NOUV)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 24, 2025, 4:00 PM EDT
NOUV Statistics
Total Valuation
NOUV has a market cap or net worth of 666,096.
Market Cap | 666,096 |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
NOUV has 6.66 billion shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 6.66B |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +492.11% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 15.60 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.00, with a Debt / Equity ratio of 9.17.
Current Ratio | 0.00 |
Quick Ratio | 0.00 |
Debt / Equity | 9.17 |
Debt / EBITDA | n/a |
Debt / FCF | -17.24 |
Interest Coverage | -5.15 |
Financial Efficiency
Return on equity (ROE) is -219.52% and return on invested capital (ROIC) is -41.53%.
Return on Equity (ROE) | -219.52% |
Return on Assets (ROA) | -19.82% |
Return on Invested Capital (ROIC) | -41.53% |
Return on Capital Employed (ROCE) | -150.27% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.00% in the last 52 weeks. The beta is -103.10, so NOUV's price volatility has been lower than the market average.
Beta (5Y) | -103.10 |
52-Week Price Change | -50.00% |
50-Day Moving Average | 0.00 |
200-Day Moving Average | 0.00 |
Relative Strength Index (RSI) | 52.82 |
Average Volume (20 Days) | 1,286,753 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.04 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -406,094 |
Pretax Income | -503,315 |
Net Income | -503,315 |
EBITDA | -163,872 |
EBIT | -406,094 |
Earnings Per Share (EPS) | -0.02 |
Balance Sheet
The company has 347 in cash and 391,237 in debt, giving a net cash position of -390,890 or -0.00 per share.
Cash & Cash Equivalents | 347 |
Total Debt | 391,237 |
Net Cash | -390,890 |
Net Cash Per Share | -0.00 |
Equity (Book Value) | 42,685 |
Book Value Per Share | 0.00 |
Working Capital | -899,219 |
Cash Flow
In the last 12 months, operating cash flow was -21,516 and capital expenditures -1,184, giving a free cash flow of -22,700.
Operating Cash Flow | -21,516 |
Capital Expenditures | -1,184 |
Free Cash Flow | -22,700 |
FCF Per Share | -0.00 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NOUV does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -9.94% |
Shareholder Yield | -9.94% |
Earnings Yield | -75.56% |
FCF Yield | -3.41% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |